Hippurate hydrolysis by and triphenyltetrazolium tolerance of Campylobacter fetus.
A rapid test of hippurate hydrolysis and a test of tolerance to triphenyltetrazolium chloride (TTC) were studied in 315 strains of Campylobacter fetus subsp. jejuni to determine their usefulness for biotyping this organism and for distinguishing it from C. fetus subsp. intestinalis. Of the 315 strains tested, 84% hydrolyzed hippurate and 97% were resistant to TTC. Ability to hydrolyze hippurate was seen in 99% of 155 human isolates, 75% of 60 avian isolates, 100% of 41 cattle and dog isolates, 84% of 31 zoo mammal isolates, and none of 28 hog isolates. Resistance to 400 micrograms of TTC per ml was seen in 97% of the human isolates, 95% of the avian isolates, and 100% of the mammalian isolates (other than human). In no case did any of the 315 isolates of C. fetus subsp. jejuni show both lack of ability to hydrolyze hippurate and sensitivity to TTC. In contrast, all 18 strains of C. fetus subsp. intestinalis failed to hydrolyze hippurate and were sensitive to TTC. These two tests may be useful to distinguish between C. fetus subsp. jejuni and subsp. intestinalis and also to biotype strains of C. fetus subsp. jejuni.
D000818:Animals; D002168:Campylobacter fetus / Q000145:classification / Q000187:drug effects / Q000378:metabolism*; D004361:Drug Tolerance; D006626:Hippurates / Q000378:metabolism*; D006801:Humans; D006868:Hydrolysis; D012703:Serotyping / Q000379:methods; D013778:Tetrazolium Salts / Q000494:pharmacology*
D006626:Hippurates; D013778:Tetrazolium Salts; C009591:triphenyltetrazolium; C030514:hippuric acid